Showing results (51-60 of 72) with videos related to
Sort By:
Pageof 8
Cancer Research|December 17, 2013
Histone chaperone CHAF1A inhibits differentiation and promotes aggressive neuroblastomaEveline Barbieri, Katleen De Preter, Mario Capasso, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 13, 2017
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with NeuroblastomaAndras Heczey, Chrystal U Louis, Barbara Savoldo, et al.Cancer Research|April 19, 2011
A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastomaJason M Shohet, Rajib Ghosh, Cristian Coarfa, et al.Cytotherapy|May 1, 2010
Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experienceConrad Russell Cruz, Patrick J Hanley, Hao Liu, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 23, 2014
Phase 1 study of intratumoral Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus, in pediatric cancer patientsTimothy P Cripe, Minhtran C Ngo, James I Geller, et al.Blood|October 11, 2011
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastomaChrystal U Louis, Barbara Savoldo, Gianpietro Dotti, et al.Pediatric Blood & Cancer|July 31, 2020
Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factorsSarah B Whittle, Valeria Smith, Allison Silverstein, et al.Cancer Research|May 21, 2013
G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenicDanielle M Hsu, Saurabh Agarwal, Ashley Benham, et al.Nature Communications|July 8, 2022
PRMT5 activates AKT via methylation to promote tumor metastasisLei Huang, Xiao-Ou Zhang, Esteban J Rozen, et al.Journal of the National Cancer Institute|May 1, 2015
The role of histone demethylase KDM4B in Myc signaling in neuroblastomaJun Yang, Alaa M AlTahan, Dongli Hu, et al.Pageof 8